Current Edition

RSP Systems to Exhibit Its Cutting-Edge Non-Invasive Glucose Monitor, GlucoBeam at ATTD 2019

RSP Systems, a Danish medical technology company focused on using state-of-the-art optical technology to non-invasively measure glucosewill showcase its advancements in product development and unveil – for the first time – its innovative device, GlucoBeam. ODENSE, Denmark, February 19, 2019

RSP Systems A/S, a Danish medical technology company focused on the development of innovative glucose monitors, today announced its participation in the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD). ATTD, one of the world’s leading scientific forums for showcasing the latest breakthroughs in diabetes technology, will be held in Berlin later this week.

Set to make its first conference appearance as an exhibitor at the prestigious New Technologies Fair, RSP Systems will unveil the version of GlucoBeam to be used in the company’s upcoming pivotal trial, a key step towards obtaining regulatory approval in Europe.

The device represents the culmination of over 10 years of research and testing to integrate the company’s proprietary critical depth Raman technology into an all-in-one consumer glucose monitor for daily home-use. While the hardware is similar to the future commercial version, the software is still being finalised in preparation for GlucoBeam’s market launch.

“We are extremely excited about the opportunity to introduce RSP Systems to industry specialists, scientists and key opinion leaders at ATTD,” said Anders Weber, CSO, who will be giving a talk at the fair. “We are also thrilled to showcase our trial-ready device and look forward to making the premium consumer version of GlucoBeam available to the public in the near future.”